Location History:
- Phoenix, AZ (US) (2015 - 2021)
- Chandler, AZ (US) (2018 - 2024)
Company Filing History:
15 out of 26 
6 out of 19 
1 out of 2 Years Active: 2015-2025
Title: Inventor Chandeshwari Chilampalli: Pioneering Innovations in Pharmaceutical Formulations
Introduction
Chandeshwari Chilampalli, an accomplished inventor based in Phoenix, AZ, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 21 patents, she has focused on developing innovative solutions for critical health issues, particularly in the areas of opioid treatment and emergency response to anaphylaxis.
Latest Patents
Among her latest patents, the liquid naloxone spray stands out. This invention encompasses stable liquid formulations containing naloxone, a pharmaceutically acceptable salt, or a derivative thereof. It also outlines methods for treating opioid overdose and opioid dependence by intranasally administering the formulations to patients in need. Another notable patent is the epinephrine spray formulation designed for treating anaphylaxis, providing a crucial method for delivering emergency care to individuals experiencing severe allergic reactions.
Career Highlights
Chandeshwari has enhanced her expertise through her work with notable companies in the pharmaceutical industry, including Hikma Pharmaceuticals USA Inc. and Insys Development Company, Inc. Her experience in these organizations has not only shaped her professional journey but has also led to groundbreaking innovations that cater to pressing healthcare challenges.
Collaborations
Throughout her career, Chandeshwari has collaborated with talented professionals, including coworkers Venkat R Goskonda and Thrimoorthy Potta. These collaborations have played a vital role in advancing her research and fostering a creative environment conducive to innovation.
Conclusion
Chandeshwari Chilampalli exemplifies the dedication and ingenuity that define successful inventors. Through her innovative patents and collaborative efforts, she continues to make a lasting impact on the pharmaceutical landscape, addressing vital health issues and enhancing the quality of care for patients across the globe.